Previous 10 | Next 10 |
home / stock / henky / henky news
The stock market is overvalued, but we can still try to find investments without overpaying. A first category of stocks are recession-proof and undervalued companies like Walgreens Boots Alliance, Henkel, Amgen or AbbVie. A second category of stocks are the outperformers like Face...
Henkel is a German conglomerate with the global #1 industrial adhesives business and solid consumer brands in beauty, home and laundry. The company has been in a turnaround since the start of 2020, after too much acquisitions and cost cuts, and not enough investments. The turnarou...
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, trusts, and offshore funds. Tweedy,...
Henkel is thus one of those "buy it and let it sleep" investments where I've been buying more shares now and then as the price drops. Cash flow-oriented shareholders should keep an eye on April 19 when Henkel is likely to go ex-dividend. In the medium term, I do not expect any exc...
In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer. Additionally, we are covering so...
Henkel AG & Co. KGaA (HENKY) Q4 2020 Earnings Conference Call March 04, 2021, 03:00 AM ET Company Participants Carsten Knobel - CEO Marco Swoboda - CFO Conference Call Participants Tom Sykes - Deutsche Bank Christian Faitz - Kepler Cheuvreux David Hayes - Societe Generale Olivier Nicolai ...
The following slide deck was published by Henkel AG & Co. KGaA in conjunction with their 2020 Q4 earnings call. For further details see: Henkel AG & Co. KGaA 2020 Q4 - Results - Earnings Call Presentation
Fiscal 2020 was challenging for Henkel, but business seems to be improving again. The company is not only recession-proof and has a wide economic moat but is also a stable dividend payer and has a solid balance sheet. Henkel is not necessarily outperforming its peers, but it seems...
H.B. Fuller delivered a good fiscal fourth quarter report, with a 6% revenue beat on the best volume growth in three years and a 9% EBITDA beat on better margins. Electronics and personal care product markets remain healthy, and autos and general industrial should accelerate throughou...
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, trusts, and offshore funds. Tweedy,...
News, Short Squeeze, Breakout and More Instantly...
Henkel AG & Co KGAA ADR Repstg Ord Shs Company Name:
HENKY Stock Symbol:
OTCMKTS Market:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Henkel AG & Co. KGAA ADR (HENKY) is expected to report for Q4 2023
Despite the latest federal interest rate hikes, undervalued stocks with impressive financials are expected to deliver solid returns in the coming months. So, we think it could be wise to scoop up quality stocks Moderna (MRNA), Bayer (BAYRY), Henkel (HENKY), AGCO (AGCO), and Penske Automotive ...